You searched for "Singing"
Absorbing the hurt
In this article, taken from his blog, ENT surgeon John McGarva reminds us that while we can’t fix everything, we may still be able to help. It was a long time ago. I was a scarily young Houseman, barely 22,...A global online fellowship in head and neck surgery and oncology
The International Federation of Head and Neck Oncologic Societies (IFHNOS) offers an online fellowship training programme for advanced trainees wishing to subspecialise in head and neck surgery and oncology. Emma Stapleton speaks with the Chairman of the Board of Directors...From the editor March/April 2023
Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTw: @Voicedoctor_uk The world of audiology and ENT will already know of the tragic death of Professor David Baguley in June 2022 at...Less than full time training: the best of both worlds!
Every one of us can feel the pressures of competing interests of everyday life and commitment to our careers. This can be even more difficult when bringing up a young family, especially when we have had to move away from...
‘FOX’ – a new software programme in cochlear implant fitting for audiologists
Taking into account the complex parameters involved in cochlear implant fitting, it appears that the procedure is becoming more and more difficult and variable across cochlear implant centres. For this reason, a software programme called FOX was designed attempting to...A quick and simple approach to correcting the deviated nasal septum
Nasal septal surgery is a very common procedure that we tend to learn as junior trainees. Most of us still find that we have a lot to learn with every deviated septum that we encounter. There is a range of...
Long-term results for dupilumab are very promising!
Eosinophilic chronic rhinosinusitis (eCRS) is complicated by frequent early and aggressive recurrence of polyps after both medical and surgical treatment regimes. Dupilumab is an anti-IL-4/IL-3 receptor monoclonal antibody and has been previously studied in the SINUS-52 study, with an observation...
